Moalem S, Percy M E, Andrews D F, Kruck T P, Wong S, Dalton A J, Mehta P, Fedor B, Warren A C
Department of Physiology, University of Toronto, Toronto, ON, Canada.
Am J Med Genet. 2000 Jul 3;93(1):58-66. doi: 10.1002/1096-8628(20000703)93:1<58::aid-ajmg10>3.0.co;2-l.
Mutations in the class I-like major histocompatibility complex gene called HFE are associated with hereditary hemochromatosis (HHC), a disorder of excessive iron uptake. We screened DNA samples from patients with familial Alzheimer disease (FAD) (n = 26), adults with Down syndrome (DS) (n = 50), and older (n = 41) and younger (n = 52) healthy normal individuals, for two HHC point mutations-C282Y and H63D. Because the apolipoprotein E (ApoE) E4 allele is a risk factor for AD and possibly also for dementia of the AD type in DS, DNA samples were also ApoE genotyped. Chi-squared analyses were interpreted at the 0.05 level of significance without Bonferroni corrections. In the pooled healthy normal individuals, C282Y was negatively associated with ApoE E4, an effect also apparent in individuals with DS but not with FAD. Relative to older normals, ApoE E4 was overrepresented in both males and females with FAD, consistent with ApoE E4 being a risk factor for AD; HFE mutations were overrepresented in males and underrepresented in females with FAD. Strong gender effects on the distribution of HFE mutations were apparent in comparisons among ApoE E4 negative individuals in the FAD and healthy normal groups (P < 0.002). Our findings are consistent with the proposition that among ApoE E4 negative individuals HFE mutations are predisposing to FAD in males but are somewhat protective in females. Further, ApoE E4 effects in our FAD group are strongest in females lacking HFE mutations. Relative to younger normals there was a tendency for ApoE E4 and H63D to be overrepresented in males and underrepresented in females with DS. The possibility that HFE mutations are important new genetic risk factors for AD should be pursued further.
一种名为HFE的I类主要组织相容性复合体基因突变与遗传性血色素沉着症(HHC)相关,这是一种铁摄取过多的疾病。我们对来自家族性阿尔茨海默病(FAD)患者(n = 26)、唐氏综合征(DS)成人患者(n = 50)以及老年(n = 41)和年轻(n = 52)健康正常个体的DNA样本进行筛查,以检测两个HHC点突变——C282Y和H63D。由于载脂蛋白E(ApoE)E4等位基因是AD以及可能也是DS中AD型痴呆的危险因素,因此还对DNA样本进行了ApoE基因分型。卡方分析在0.05的显著性水平下进行解释,未进行Bonferroni校正。在合并的健康正常个体中,C282Y与ApoE E4呈负相关,这种效应在DS个体中也很明显,但在FAD个体中不明显。相对于老年正常个体,ApoE E4在FAD的男性和女性中均过度表达,这与ApoE E4是AD的危险因素一致;HFE突变在FAD的男性中过度表达,在女性中表达不足。在FAD和健康正常组的ApoE E4阴性个体之间的比较中,HFE突变分布存在明显的性别效应(P < 0.002)。我们的研究结果与以下观点一致:在ApoE E4阴性个体中,HFE突变使男性易患FAD,但对女性有一定的保护作用。此外,在我们的FAD组中,ApoE E4效应在缺乏HFE突变的女性中最强。相对于年轻正常个体,ApoE E4和H63D在DS的男性中倾向于过度表达,在女性中表达不足。HFE突变是AD重要新遗传危险因素的可能性应进一步探究。